Investment Analysts’ Weekly Ratings Changes for Omega Healthcare Investors (OHI)

A number of research firms have changed their ratings and price targets for Omega Healthcare Investors (NYSE: OHI):

• 1/12/2026 – Omega Healthcare Investors was downgraded by analysts at Weiss Ratings from a “buy (a-)” rating to a “buy (b+)” rating.
• 1/9/2026 – Omega Healthcare Investors is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $54.00 price target on the stock.
• 1/9/2026 – Omega Healthcare Investors was downgraded by analysts at BMO Capital Markets from an “outperform” rating to a “market perform” rating. They now have a $45.00 price target on the stock.
• 1/9/2026 – Omega Healthcare Investors is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $54.00 price target on the stock.
• 1/8/2026 – Omega Healthcare Investors had its price target raised by analysts at UBS Group AG from $50.00 to $51.00. They now have a “buy” rating on the stock.
• 12/29/2025 – Omega Healthcare Investors had its “buy (a-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – Omega Healthcare Investors was upgraded by analysts at Weiss Ratings from a “buy (b+)” rating to a “buy (a-)” rating.
• 12/15/2025 – Omega Healthcare Investors had its “hold” rating reaffirmed by analysts at Jefferies Financial Group Inc.. They now have a $45.00 price target on the stock.
• 12/1/2025 – Omega Healthcare Investors had its price target raised by analysts at Truist Financial Corporation from $44.00 to $46.00. They now have a “hold” rating on the stock.
• 11/25/2025 – Omega Healthcare Investors had its price target raised by analysts at Wells Fargo & Company from $45.00 to $48.00. They now have an “overweight” rating on the stock.
• 11/18/2025 – Omega Healthcare Investors is now covered by analysts at UBS Group AG. They set a “buy” rating and a $50.00 price target on the stock.

Omega Healthcare Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, November 17th. Investors of record on Monday, November 3rd were issued a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 6.0%. The ex-dividend date was Monday, November 3rd. Omega Healthcare Investors’s payout ratio is presently 149.72%.

Insider Transactions at Omega Healthcare Investors

In other Omega Healthcare Investors news, CIO Vikas Gupta bought 11,500 shares of the business’s stock in a transaction on Thursday, November 6th. The shares were acquired at an average price of $42.97 per share, with a total value of $494,155.00. Following the transaction, the executive owned 13,773 shares of the company’s stock, valued at approximately $591,825.81. This trade represents a 505.94% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO C Taylor Pickett acquired 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 5th. The shares were acquired at an average cost of $43.14 per share, for a total transaction of $862,800.00. Following the completion of the acquisition, the chief executive officer owned 20,000 shares of the company’s stock, valued at $862,800. This trade represents a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 1.50% of the stock is owned by corporate insiders.

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.